Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1986 | 5072 | 28.1 | 61% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
24 | 112627 | HYPERTENSION//JOURNAL OF HYPERTENSION//HEART FAILURE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
1035 | 2802 | CAS 89396 94 1//TA 6366//MOEXIPRIL |
3656 | 1859 | HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA |
24008 | 273 | ADR MONITORING//BOVINE BRONCHI//ACE I INHIBITOR |
30399 | 138 | TRANDOLAPRIL//MULTI PHOTON CONTAMINATION//VERAPAMIL SR TRANDOLAPRIL COMBINATION THERAPY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEREDITARY ANGIOEDEMA | Author keyword | 606 | 86% | 6% | 304 |
2 | C1 INHIBITOR | Author keyword | 213 | 70% | 4% | 178 |
3 | ANGIOEDEMA | Author keyword | 170 | 48% | 5% | 261 |
4 | C1 INHIBITOR DEFICIENCY | Author keyword | 152 | 89% | 1% | 70 |
5 | ECALLANTIDE | Author keyword | 98 | 100% | 1% | 29 |
6 | C1 ESTERASE INHIBITOR | Author keyword | 74 | 66% | 1% | 69 |
7 | HAE | Author keyword | 64 | 86% | 1% | 32 |
8 | ACQUIRED ANGIOEDEMA | Author keyword | 61 | 86% | 1% | 31 |
9 | C1 INH | Author keyword | 46 | 82% | 1% | 27 |
10 | C1 INHIBITOR CONCENTRATE | Author keyword | 34 | 93% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEREDITARY ANGIOEDEMA | 606 | 86% | 6% | 304 | Search HEREDITARY+ANGIOEDEMA | Search HEREDITARY+ANGIOEDEMA |
2 | C1 INHIBITOR | 213 | 70% | 4% | 178 | Search C1+INHIBITOR | Search C1+INHIBITOR |
3 | ANGIOEDEMA | 170 | 48% | 5% | 261 | Search ANGIOEDEMA | Search ANGIOEDEMA |
4 | C1 INHIBITOR DEFICIENCY | 152 | 89% | 1% | 70 | Search C1+INHIBITOR+DEFICIENCY | Search C1+INHIBITOR+DEFICIENCY |
5 | ECALLANTIDE | 98 | 100% | 1% | 29 | Search ECALLANTIDE | Search ECALLANTIDE |
6 | C1 ESTERASE INHIBITOR | 74 | 66% | 1% | 69 | Search C1+ESTERASE+INHIBITOR | Search C1+ESTERASE+INHIBITOR |
7 | HAE | 64 | 86% | 1% | 32 | Search HAE | Search HAE |
8 | ACQUIRED ANGIOEDEMA | 61 | 86% | 1% | 31 | Search ACQUIRED+ANGIOEDEMA | Search ACQUIRED+ANGIOEDEMA |
9 | C1 INH | 46 | 82% | 1% | 27 | Search C1+INH | Search C1+INH |
10 | C1 INHIBITOR CONCENTRATE | 34 | 93% | 0% | 13 | Search C1+INHIBITOR+CONCENTRATE | Search C1+INHIBITOR+CONCENTRATE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANGIONEUROTIC EDEMA | 643 | 91% | 5% | 266 |
2 | C1 INHIBITOR DEFICIENCY | 452 | 88% | 4% | 215 |
3 | C1 INHIBITOR CONCENTRATE | 379 | 95% | 3% | 128 |
4 | C1 INHIBITOR | 208 | 58% | 5% | 239 |
5 | ACQUIRED C1 INHIBITOR DEFICIENCY | 188 | 92% | 1% | 76 |
6 | HEREDITARY ANGIONEUROTIC EDEMA | 164 | 77% | 2% | 110 |
7 | HEREDITARY ANGIOEDEMA | 135 | 50% | 4% | 195 |
8 | C1 ESTERASE INHIBITOR | 113 | 59% | 2% | 126 |
9 | ESTERASE INHIBITOR | 110 | 78% | 1% | 72 |
10 | ACUTE ATTACKS | 88 | 72% | 1% | 69 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group | 2014 | 36 | 101 | 96% |
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group | 2012 | 120 | 55 | 95% |
COUGH AND ANGIONEUROTIC-EDEMA ASSOCIATED WITH ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY - A REVIEW OF THE LITERATURE AND PATHOPHYSIOLOGY | 1992 | 580 | 130 | 73% |
Angiotensin-converting Enzyme Inhibitor-induced Angioedema | 2015 | 2 | 35 | 77% |
C1 inhibitor deficiency: consensus document | 2005 | 221 | 73 | 85% |
Hereditary angioedema - A broad review for clinicians | 2001 | 155 | 74 | 88% |
Facilitating home-based treatment of hereditary angioedema | 2015 | 1 | 37 | 92% |
Consensus Statement on the Diagnosis, Management, and Treatment of Angioedema Mediated by Bradykinin. Part I. Classification, Epidemiology, Pathophysiology, Genetics, Clinical Symptoms, and Diagnosis | 2011 | 42 | 130 | 82% |
CONVERTING-ENZYME INHIBITORS IN THE TREATMENT OF HYPERTENSION | 1988 | 369 | 70 | 76% |
Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration | 2013 | 12 | 27 | 100% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REFERENCE ANGIOEDEMA | 26 | 100% | 0.2% | 11 |
2 | ANGIOEDEMA | 20 | 100% | 0.2% | 9 |
3 | MU CTY HOSP | 15 | 82% | 0.2% | 9 |
4 | HAE DENMARK | 11 | 100% | 0.1% | 6 |
5 | REFERENCE ANGIOEDEMES CREAK | 11 | 100% | 0.1% | 6 |
6 | CLIN UNIV MED INTERNE | 10 | 58% | 0.2% | 11 |
7 | ALLERGOL ANGIOEDEMA OUTPATIENT CLIN | 8 | 100% | 0.1% | 5 |
8 | BIOMED NETWORK RARE DIS CIBERER U754 | 8 | 100% | 0.1% | 5 |
9 | ALLERGOL ANGIOOEDEMA OUTPATIENT CLIN | 6 | 100% | 0.1% | 4 |
10 | COMPLEMENT | 5 | 50% | 0.1% | 7 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020856 | ANGIOTENSIN II//ANGIOTENSIN 1 7//RENIN ANGIOTENSIN SYSTEM |
2 | 0.0000019978 | BRADYKININ//FACTOR XII//B 1 RECEPTOR |
3 | 0.0000017404 | LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER |
4 | 0.0000013506 | CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE |
5 | 0.0000011044 | TORASEMIDE//HYPERKALEMIA//FUROSEMIDE |
6 | 0.0000010956 | FAMILIAL MEDITERRANEAN FEVER//CHRONIC URTICARIA//MEFV |
7 | 0.0000010399 | CARVEDILOL//NEBIVOLOL//BETA BLOCKERS |
8 | 0.0000009642 | RENAL ARTERY STENOSIS//TAKAYASUS ARTERITIS//TAKAYASU ARTERITIS |
9 | 0.0000009357 | LEFT VENTRICULAR HYPERTROPHY//POST EXERCISE HYPOTENSION//LEFT VENTRICULAR MASS |
10 | 0.0000008392 | MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL |